Using Digested and Lyophilized Bone Matrices to Enhance Retention and Sustained Release of BMP-2 for Bone...

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Human recombinant bone morphogenetic protein 2 (rhBMP-2) promotes bone formation but carries risks like inflammation and ectopic bone.
• Controlled, prolonged release of rhBMP-2 improves bone healing and reduces side effects compared to short-term delivery.
• Existing collagen sponges have limitations in structural stability and release profiles for rhBMP-2 delivery.

Purpose of the Study:

• To develop and evaluate a novel bone matrix scaffold for sustained delivery of synthetic BMP2 (sBMP2).
• To assess the in vitro release kinetics and in vivo bone regenerative capacity of the new scaffold.
• To provide a safer and more effective rhBMP-2 delivery system, particularly for pediatric applications.

Main Methods:

• A bone matrix scaffold was created from decellularized, demineralized, and digested porcine bone.
• Synthetic BMP2 (sBMP2) was infused into the matrix and stabilized using glutaraldehyde (GL) crosslinking, forming the DLBM/sBMP2/GL scaffold.
• In vitro sBMP2 release was measured, and in vivo bone regeneration was assessed in a rat tibial defect model.

Main Results:

• The DLBM/sBMP2/GL scaffold demonstrated prolonged and sustained in vitro release of sBMP2.
• The scaffold exhibited biocompatibility and osteogenicity in vivo.
• Substantial bone regeneration was observed, correlating with gradual scaffold degradation and sustained sBMP2 release.

Conclusions:

• The DLBM/sBMP2/GL scaffold is a promising alternative bone graft material.
• It offers improved safety and efficacy for pediatric bone healing compared to current methods.
• This innovative delivery system addresses the need for enhanced rhBMP-2 delivery in bone regeneration applications.